5P12-RANTES / Orion Biotech 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
5P12-RANTES / Orion Biotech
NCT05940844: Study of OB-002 in Patients With Refractory Metastatic Cancer

Not yet recruiting
1b
36
NA
OB-002
Orion Biotechnology Polska Sp. z o.o.
Metastatic Cancer, Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer, Metastatic Gastric Cancer, Metastatic Breast Cancer, Metastatic Urothelial Carcinoma
04/25
08/25

Download Options